Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMpella®-Protected cArdiaC Surgery Trial in Europe: A European, Prospective, Multicenter, Post-Market Clinical Follow-Up Trial

NCT05756751 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT05756751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05756751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMpella®-Protected cArdiaC Surgery Trial in Europe: A European, Prospective, Multicenter, Post-Market Clinical Follow-Up Trial
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 27, 2023
Completion date
August 8, 2026
Enrollment
123 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular dysfunction